Abbott Molecular, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Jan 27, 2023
  • 5 Class I recalls
  • Last warning letter 2009
Inspections 16 1 OAI
Recalls 36 5 Class I (14%)
Warning letters 1 Latest Aug 12, 2009
510(k) clearances 19 Latest Sep 25, 2025

Abbott Molecular, Inc. has 36 FDA recalls (5 Class I), 16 inspections, 19 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Abbott Molecular, Inc., the most recent on Aug 12, 2009.

What these totals cover: FDA records filed under the name "Abbott Molecular, Inc." and its spelling variant "Abbott Molecular". They do not include records filed under Abbott Laboratories or other names in its corporate family; those are listed under Related names, each with its own counts.

Latest recall
Z-0191-2027 · Sep 10, 2026 · filed under Abbott
Latest recall under this name
Z-1749-2025 · Class II · Apr 28, 2025
Latest inspection
Jan 27, 2023 · VAI
Latest 510(k)
Sep 25, 2025

Newer recall under related name Abbott: Sep 10, 2026, Z-0191-2027.

Part of the Abbott Laboratories corporate family.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls36 (5 Class I)Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026Current
510(k) clearances19Nov 22, 2026File dated Nov 18, 2026Current
Inspections16Nov 22, 2026Newest record Nov 9, 2026Current
Compliance actions1Nov 22, 2026Newest record Nov 13, 2026Current

FDA record by year

Abbott Molecular, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Abbott Molecular, Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 10 recall records (5 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 10 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500030
202400060
202310010
2022000100
2021100105
202000000
201910000
201810000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Abbott Molecular, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Abbott Molecular, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Abbott Molecular, Inc. FDA Warning Letters

1 warning letter on Aug 12, 2009.

IssuedSubjectIssuing officeClose-out letter
Aug 12, 2009 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

36 recall records from Jan 31, 2012 to Apr 28, 2025. Showing the 20 most recent. View all 36 recall records

NumberClassProductDate
Z-1749-2025Class IIAlinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription…Apr 28, 2025
Z-1748-2025Class IIAlinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time…Apr 28, 2025
Z-1665-2025Class IIThe Alinity m System is designed to automate the steps for nucleic acid testing. Model Numbers…Mar 20, 2025
Z-0233-2025Class IIAbbott Alinity m HPV AMP Kit, used with the Alinity m System, product codes: a) REF 09N15-095; b)…Sep 12, 2024
Z-0234-2025Class IIAbbott Alinity m STI AMP Kit, used with the Alinity m System, product codes: a) REF 09N17-095; b)…Sep 12, 2024
Z-1602-2024Class IIAlinity m System, Part Number: 08N53-002Mar 20, 2024
Z-1190-2024Class IIIWash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare…Feb 1, 2024
Z-1189-2024Class IIIIn-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020…Feb 1, 2024
Z-1188-2024Class IIIIn-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2)…Feb 1, 2024
Z-0407-2024Class IIAlinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay…Oct 30, 2023
Z-1009-2023Class IIAlinity m System. The Alinity m System is designed to automate the steps for nucleic acid…Dec 9, 2022
Z-0740-2023Class IIAbbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-090Nov 22, 2022
Z-0739-2023Class IIAbbott Alinity m Resp-4-Plex Amp Kit, Part Number 09N79-096Nov 22, 2022
Z-1349-2023Class IIAbbott Alinity m System, REF 08N53-002, containing Amplification Detetction Unit (ADU) #4.Nov 11, 2022
Z-0268-2023Class IIAlinity m System, REF 08N53-002, For In Vitro Diagnostic UseOct 12, 2022
Z-1679-2022Class IIAbbott Alinity m SARS-CoV-2 CTRL Kit, REF 09N78-085, each kit contains 12 x 1.3mL CTRL - and 12 x…Aug 19, 2022
Z-1518-2022Class IIThe Alinity m System, REF 08N53-002, For In Vitro Diagnostic Use.Jul 19, 2022
Z-0883-2022Class IIAlinity m HBV Application Specification File (US and CE)Mar 4, 2022
Z-0884-2022Class IIAlinity m HBV AMP Kit (US and CE)Mar 4, 2022
Z-0710-2022Class IIAlinity m Integrated Reaction Units (IRU)Feb 11, 2022

Recent FDA inspections

16 inspections from Feb 13, 2009 to Jan 27, 2023.

DateSiteProductClassificationFEI
Jan 27, 2023Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Feb 19, 2021Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Jul 10, 2019Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Sep 20, 2018Des Plaines, ILBiologicsNo Action Indicated (NAI)3005248192
May 4, 2017Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Mar 31, 2016Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Feb 3, 2016Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Jul 11, 2014Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Feb 21, 2013Des Plaines, ILDevicesNo Action Indicated (NAI)3005248192
Jul 11, 2012Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Jun 1, 2011Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
May 24, 2011Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Jul 23, 2010Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Mar 10, 2010Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
Jun 29, 2009Des Plaines, ILDevicesOfficial Action Indicated (OAI)3005248192
Feb 13, 2009Des Plaines, ILDevicesVoluntary Action Indicated (VAI)3005248192
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Abbott Molecular, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Aug 12, 2009.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3005248192Des Plaines, IL16Jan 27, 2023

Recent 510(k) clearances

19 510(k) clearances from Jul 10, 2008 to Sep 25, 2025.

K-NumberDeviceDate
K252102Alinity m HCVSep 25, 2025
K243489Alinity m EBV (09N43-095)Jul 28, 2025
K243485Alinity m CMVJul 1, 2025
K241921Alinity m BKVMar 24, 2025
K241573Alinity m Resp-4-PlexFeb 14, 2025
K243410simpli-COLLECT STI TestJan 30, 2025
K241580Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086)Dec 6, 2024
K233349Alinity m HSV 1 & 2 / VZVMay 3, 2024
K222379Alinity m STI AssayMar 3, 2023
K212778Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m…Jul 15, 2022
K202977Alinity m STI AssayApr 29, 2022
K140354ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, ABBOTT REAL TIME CT/NGMay 9, 2014
K131508VYSIS D7S486/CEP 7 FISH PROBE KITSep 13, 2013
DEN130010VYSIS EGR1 FISH PROBE KIT - SC (SPECIMEN CHARACTERIZATION)Jul 29, 2013
K091960VYSIS EGR1 FISH PROBE KIT (VYSIS LSI EGR1 SPECTRUM/ORANGE/D5S23, D5S721, SPECTRUM GREEN PROBE)…Aug 29, 2011
K100015VYSIS CLL FISH PROBE KIT (VYSIS LSI TP53 SPECTRUMORANGE/ATM SPECTRUMGREEN) AND LSI D135319…Aug 9, 2011
K092704ABBOTT REALTIME CT/NG AND ABBOTT MULTI-COLLECT SPECIMEN COLLECTION KIT, MODELS 8L07-91, 9K12-03May 28, 2010
K092705ABBOTT M2000SP AND ABBOTT M2000RT, MODELS 9K14-01 (G-SERIES), 9K14-02 (E-SERIES), 9K1501May 28, 2010
K080739ABBOTT REALTIME CT/NG ASSAY AND MULTI-COLLECT SPECIMEN COLLECTION KITJul 10, 2008

Abbott Molecular, Inc. and the FDA: common questions

Has Abbott Molecular, Inc. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Abbott Molecular, Inc.. The most recent is dated Aug 12, 2009.

Has Abbott Molecular, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Abbott Molecular, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Abbott Molecular, Inc.?

The most recent FDA inspection on file ended Jan 27, 2023 at Des Plaines, IL and was classified VAI. FDA has 16 inspections of Abbott Molecular, Inc. on file, 1 of them classified OAI (official action indicated).

Has Abbott Molecular, Inc. had an FDA recall?

Yes. Abbott Molecular, Inc. has 36 FDA recalls on record, 5 of them Class I, the most serious class. The most recent under this name started Apr 28, 2025. A newer recall, dated Sep 10, 2026, is filed under the related name Abbott.

Need more than this page shows? Ask about Abbott Molecular, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.